Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0510
0.00 (0.00%)
Mar 9, 2026, 9:30 AM EST
Telesis Bio Employees
Telesis Bio had 39 employees as of September 30, 2024. The number of employees decreased by 108 or -73.47% compared to the same quarter last year.
Employees
39
Change
-108
Growth
-73.47%
Revenue / Employee
$436,769
Profits / Employee
-$1,228,872
Market Cap
91.89K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2024 | 39 | -108 | -73.47% | 39 | 0 |
| Jun 30, 2024 | 110 | - | - | 101 | 9 |
| Mar 31, 2024 | 138 | -105 | -43.21% | 127 | 11 |
| Dec 31, 2023 | 147 | -96 | -39.51% | 137 | 10 |
| Dec 31, 2022 | 243 | 7 | 2.97% | 223 | 20 |
| Jun 30, 2022 | 182 | 74 | 68.52% | 182 | 0 |
| Mar 31, 2022 | 264 | 163 | 161.39% | 264 | 0 |
| Dec 31, 2021 | 236 | 145 | 159.34% | 212 | 24 |
| Sep 30, 2021 | 133 | 42 | 46.15% | 133 | 0 |
| Jun 30, 2021 | 108 | - | - | 108 | 0 |
| Mar 31, 2021 | 101 | - | - | 101 | 0 |
| Dec 31, 2020 | 91 | - | - | 91 | 0 |
Telesis Bio News
- 1 year ago - Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis - GlobeNewsWire
- 1 year ago - Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market - GlobeNewsWire
- 1 year ago - Telesis Bio Reports Second Quarter and First Half 2024 Financial Results - GlobeNewsWire
- 1 year ago - Telesis Bio Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 years ago - Telesis Bio Announces Reverse Stock Split - GlobeNewsWire
- 2 years ago - Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership - GlobeNewsWire
- 2 years ago - Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 2 years ago - Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results - GlobeNewsWire